Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7239)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2017 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Actis GC, Pellicano R. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment. World J Gastrointest Pharmacol Ther 2017; 8(2): 114-119 [PMID: PMC5421109 DOI: 10.4292/wjgpt.v8.i2.114] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/114.htm |
| Number | Citing Articles |
| 1 |
Lei Wang, Rong Fan, Chen Zhang, Liwen Hong, Tianyu Zhang, Ying Chen, Kai Liu, Zhengting Wang, Jie Zhong. <p>Applying Machine Learning Models to Predict Medication Nonadherence in Crohn’s Disease Maintenance Therapy</p>. Patient Preference and Adherence 2020; : 917 doi: 10.2147/PPA.S253732
|
| 2 |
Laura R. Lanters, Hanna Öhlmann, Jost Langhorst, Nina Theysohn, Harald Engler, Adriane Icenhour, Sigrid Elsenbruch. Disease-specific alterations in central fear network engagement during acquisition and extinction of conditioned interoceptive fear in inflammatory bowel disease. Molecular Psychiatry 2024; 29(11): 3527 doi: 10.1038/s41380-024-02612-7
|
| 3 |
Bjørn Hanger. Transforming Care in SEA: Evidence and Considerations for Evolution of the Current Treatment Paradigm. EMJ Respiratory 2024; : 41 doi: 10.33590/emjrespir/DMFU7675
|
| 4 |
Shahnaz Khan, Ewa Rupniewska, Mackenzie Neighbors, David Singer, Joseph Chiarappa, Camilo Obando. Real‐world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review. Journal of Clinical Pharmacy and Therapeutics 2019; doi: 10.1111/jcpt.12830
|
| 5 |
Brittany E. Levy, Anthony A. Mangino, Jennifer T. Castle, Wesley A. Stephens, Hannah G. McDonald, Jitesh A. Patel, Sandra J. Beck, Avinash S. Bhakta. Effect of Medicaid expansion on inflammatory bowel disease and healthcare utilization. The American Journal of Surgery 2024; 232: 102 doi: 10.1016/j.amjsurg.2024.01.015
|
| 6 |
Rodrigo de Oliveira Formiga, Edvaldo Balbino Alves Júnior, Roseane Carvalho Vasconcelos, Gerlane Coelho Bernardo Guerra, Aurigena Antunes de Araújo, Thaís Gomes de Carvalho, Vinícius Barreto Garcia, Raimundo Fernandes de Araújo Junior, Francisco Allysson Assis Ferreira Gadelha, Giciane Carvalho Vieira, Marianna Vieira Sobral, José Maria Barbosa Filho, Fernando Spiller, Leônia Maria Batista. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. International Journal of Molecular Sciences 2020; 21(16): 5870 doi: 10.3390/ijms21165870
|
| 7 |
Francesc Casellas, Yago González-Lama, Daniel Ginard Vicens, Santiago García-López, Fernando Muñoz, Laura Marín Sánchez, Laura Camacho, Ana Cabez, Pilar Fortes, Susana Gómez, Pablo Bella Castillo, Manuel Barreiro-de Acosta. Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document. Revista Española de Enfermedades Digestivas 2021; doi: 10.17235/reed.2021.8130/2021
|
| 8 |
Maria Elaine Cristina Araruna, Edvaldo Balbino Alves Júnior, Catarina Alves de Lima Serafim, Matheus Marley Bezerra Pessoa, Michelle Liz de Souza Pessôa, Vitória Pereira Alves, Marianna Vieira Sobral, Marcelo Sobral da Silva, Adriano Francisco Alves, Maria Carolina de Paiva Sousa, Aurigena Antunes Araújo, Leônia Maria Batista. (-)-Fenchone Ameliorates TNBS-Induced Colitis in Rats via Antioxidant, Immunomodulatory, and Cytoprotective Mechanisms. Pharmaceuticals 2024; 18(1): 18 doi: 10.3390/ph18010018
|
| 9 |
Vipul Jairath, Russell D. Cohen, Edward V. Loftus, Ninfa Candela, Karen Lasch, Bob G. Schultz. Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02590-6
|
| 10 |
Joseph Diab, Terkel Hansen, Rasmus Goll, Hans Stenlund, Maria Ahnlund, Einar Jensen, Thomas Moritz, Jon Florholmen, Guro Forsdahl. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State. Inflammatory Bowel Diseases 2019; 25(11): 1780 doi: 10.1093/ibd/izz098
|
| 11 |
Peri Newman, Joshua Muscat. Potential Role of Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention for Inflammatory Bowel Disease: An Umbrella Review. Cancers 2023; 15(4): 1102 doi: 10.3390/cancers15041102
|
| 12 |
Jennifer T. Castle, Brittany E. Levy, Anthony A. Mangino, Hannah G. McDonald, Erin E. McAtee, Jitesh A. Patel, B. Mark Evers, Avinash S. Bhakta. Impact of the Affordable Care Act on Providing Equitable Healthcare Access for IBD in the Kentucky Appalachian Region. Diseases of the Colon & Rectum 2023; 66(9): 1273 doi: 10.1097/DCR.0000000000002942
|